2014-11-14 – Page 8 – China Stock Advice

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[o Large accelerated filer o Accelerated filer o Non-accelerated filer (Do not check if a smaller reporting company)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093014.htm]

By info| 2016-03-28T19:32:05+00:00 November 14th, 2014|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2014-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

HOLI [Hollysys Automation Technologies] 6-K: Hollysys Automation Technologies Reports Unaudited Financial Results for

[Hollysys Automation Technologies Reports Unaudited Financial Results for the First Quarter of Fiscal Year 2015 Ended September 30, 2014 First Quarter of Fiscal Year 2015 Financial Highlights · Total revenues · Non-GAAP gross margin · Non-GAAP net income attributable to Hollysys · Non-GAAP diluted EPS · Integrated Contracts Backlog · Quarterly DSO · Inventory turnover days · cash and cash] [FORM 6-K HOLLYSYS AUTOMATION TECHNOLOGIES, LTD. No.2 Disheng Middle Road Beijing Economic-Technological Development Area Beijing, People's Republic of China, 100176 Q £ £ Q Hollysys Automation Technologies Reports Unaudited Financial Results for the First Quarter of Fiscal Year 2015 Ended September 30, 2014 Beijing, China – November 14, 2014 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company"),]

By info| 2016-03-31T17:02:16+00:00 November 14th, 2014|Categories: Chinese Stocks, HOLI, Webplus ver|Tags: 0001357450, 2014-11-14, 3620, 6-K, ELECTRICAL INDUSTRIAL APPARATUS, HOLI|0 Comments

JRJC [China Finance Online] 6-K: Change of Auditor “ Company ” or “

[Change of Auditor “ Company ” or “ we ” “ GT ” Shu Lun Pan Certified Public Accountants LLP On November 4, 2014, China Finance Online Co. Limited (the During the two most recent fiscal years ended December 31, 2013 and through the date of this Form 6-K: (i) There were no disagreements between the Company and GT on]

By info| 2016-03-13T18:37:24+00:00 November 14th, 2014|Categories: Chinese Stocks, JRJC, Webplus ver|Tags: 0001297830, 2014-11-14, 6-K, 6211, JRJC, SECURITY BROKERS, DEALERS and FLOTATION COMPANIES|0 Comments

SORL [SORL Auto Parts] 10-Q: (Original Filing)

[] [of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification of Principal Financial Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: November 14, 2014 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-18T21:17:37+00:00 November 14th, 2014|Categories: Chinese Stocks, SEC Original, SORL|Tags: 0000714284, 10-Q, 2014-11-14, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

CLNT [Cleantech Solutions International] 10-Q:

[] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER SARBANES-OXLEY ACT OF 2002 I, Adam Wasserman, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianhua Wu Chief Executive Officer Adam Wasserman Chief Financial Officer (Principal Accounting Officer) EX-32.1 4 f10q0914ex32i_cleantech.htm CERTIFICATION]

By info| 2016-03-26T12:04:10+00:00 November 14th, 2014|Categories: Chinese Stocks, CLNT, Webplus ver|Tags: 0000819926, 10-Q, 2014-11-14, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

CPHI [CHINA PHARMA] 10-Q: o Large accelerated filer o Accelerated filer o

[o Large accelerated filer o Accelerated filer o Non-accelerated filer (Do not check if a smaller reporting company)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321093014.htm]

By info| 2016-03-28T19:33:31+00:00 November 14th, 2014|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2014-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

AMCF [Andatee China Marine Fuel Services] 10-Q: (Original Filing)

[] [CERTIFICATION I, Wang Hao, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Quan Zhang, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Wang Hao President, Chief Executive Officer] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Quan Zhang Chief Financial Officer (Principal Financial and Accounting Officer)]

By info| 2016-04-01T23:08:16+00:00 November 14th, 2014|Categories: AMCF, Chinese Stocks, SEC Original|Tags: 0001469606, 10-Q, 2014-11-14, 5171, AMCF, WHOLESALE-PETROLEUM BULK STATIONS and TERMINALS|0 Comments

ONP [Orient Paper] 8-K: (Original Filing)

[Orient Paper, Inc. Reports Third Quarter 2014 Results BAODING, China, Nov. 13, 2014 /PRNewswire/ -- Orient Paper, Inc. (NYSE MKT: ONP) ("Orient Paper" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced unaudited financial results for the third quarter ended September 30, 2014. Financial Highlights: US$ million 3Q 2014 YOY Change 9M] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): November 13, 2014 ORIENT PAPER, INC. Nevada (State or Other Jurisdiction of Incorporation) 001-34577 20-4158835 (IRS Employer Identification No.) Science Park, Juli Road Xushui County, Baoding City Hebei Province, People’s Republic of China 072550 (Zip Code) (86) 312-8698215 (Former Name or Former Address, if Changed Since Last Report)]

By info| 2016-03-13T20:14:47+00:00 November 14th, 2014|Categories: Chinese Stocks, ONP, SEC Original|Tags: 0001358190, 2014-11-14, 2670, 8-K, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

SORL [SORL Auto Parts] 10-Q:

[] [of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification of Principal Financial Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: November 14, 2014 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer (Principal Financial Officer)]

By info| 2016-03-18T21:18:27+00:00 November 14th, 2014|Categories: Chinese Stocks, SORL, Webplus ver|Tags: 0000714284, 10-Q, 2014-11-14, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [EMPLOYMENT AGREEMENT Agreement Executive Company This EMPLOYMENT AGREEMENT (this “ WHEREAS, the Company desires to employ Executive as its Chief Financial Officer on the terms and conditions as set forth hereinafter, and Executive desires to be so employed; NOW, THEREFORE, IN CONSIDERATION of the foregoing facts, the mutual covenants and agreements contained herein and other good and valuable consideration, the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2014 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2014 Bing Mei Chief Financial Officer]

By info| 2016-03-27T15:40:21+00:00 November 14th, 2014|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2014-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments